Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: METACLIPSE THERAPEUTICS CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-05 to 2026-09-04
Current total value of award: $354957
Description: SBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS